1. ONUSIDA: Rapport mondial : Rapport ONUSIDA sur l’épidémie mondiale de sida 2013. 2013, Genève: ONUSIDA
2. ONUSIDA: Traitement 2015. 2013, Genève: ONUSIDA, http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/JC2484_treatment-2015_fr.pdf, consulté le 26 avril 2014
3. Peretti-Watel P, Spire B, Schiltz MA, Bouhnik AD, Heard I, Lert F, Obadia Y: Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006, 62: 2420-2433. 10.1016/j.socscimed.2005.10.020.
4. Pennap GR, Abdullahi U, Bako IA: Adherence to highly active antiretroviral therapy and its challenges in people living with human immunodeficiency virus (HIV) infection in Keffi, Nigeria. J AIDS HIV Res. 2013, 5: 52-58.
5. Meresse M, March L, Kouanfack C, Bonono R-C, Boyer S, Laborde-Balen G, Aghokeng A, Suzan-Monti M, Delaporte E, Spire B, Carrieri MP, Laurent C: Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon. HIV Med. 2014, doi:10.1111/hiv.12140